August 13, 2019 / 12:42 PM / a month ago

BRIEF-Health Canada Approves Tecentriq In Combination With Carboplatin & Etoposide

Aug 13 (Reuters) - Roche Holding AG:

* HEALTH CANADA APPROVES TECENTRIQ® (ATEZOLIZUMAB), FIRST NEW TREATMENT IN 20 YEARS FOR AGGRESSIVE FORM OF LUNG CANCER(1)

* ROCHE CANADA - SAFETY PROFILE OF TECENTRIQ IN COMBINATION WITH CARBOPLATIN & ETOPOSIDE CONSISTENT WITH KNOWN RISKS OF INDIVIDUAL TREATMENT COMPONENTS

* ROCHE CANADA - HEALTH CANADA APPROVED TECENTRIQ IN COMBINATION WITH CARBOPLATIN & ETOPOSIDE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below